NeoGenomics director awarded RSUs and stock options
NEOGENOMICS INC director Carolyn S. Starrett reported receiving new equity awards.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NEOGENOMICS INC director Carolyn S. Starrett reported receiving new equity awards. On 2026-06-23, she was granted 14,125 Restricted Stock Units, each representing one share of common stock when vested. She was also granted stock options for 9,784 shares of common stock at an exercise price of $11.20 per share, expiring on 2036-06-01. A footnote states that once vested, the common shares underlying these awards are not subject to expiration.
Insider Trade Summary
Grant/Award: 23,909 shares
Grant/Award
2 txns
Insider
Starrett Carolyn S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,784 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 14,125 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,784 contracts (Direct);
Restricted Stock Unit — 14,125 contracts (Direct)
Footnotes (1)
- F1. Once vested, the shares of common stock are not subject to expiration.
Key Figures
RSU grant size: 14,125 units
Option grant size: 9,784 options
Option exercise price: $11.20 per share
+3 more
6 metrics
RSU grant size
14,125 units
Restricted Stock Units granted on 2026-06-23
Option grant size
9,784 options
Stock Option (Right to Buy) granted on 2026-06-23
Option exercise price
$11.20 per share
Conversion or exercise price for stock options
Option expiration
2036-06-01
Expiration date for stock options
RSU underlying shares
14,125 shares
Common stock underlying RSU award
Options underlying shares
9,784 shares
Common stock underlying option award
Key Terms
Restricted Stock Unit, Stock Option (Right to Buy), exercise price, expiration date
4 terms
Restricted Stock Unit financial
"she was granted 14,125 Restricted Stock Units, each representing one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"She was also granted stock options for 9,784 shares of common stock"
exercise price financial
"stock options for 9,784 shares of common stock at an exercise price of $11.20 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"stock options for 9,784 shares of common stock at an exercise price of $11.20 per share, expiring on 2036-06-01"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NEOGENOMICS INC (NEO) report for Carolyn S. Starrett?
NEOGENOMICS INC reported that director Carolyn S. Starrett received two equity awards on 2026-06-23. She was granted 14,125 Restricted Stock Units and stock options for 9,784 shares of common stock at an exercise price of $11.20 per share.
How many Restricted Stock Units did Carolyn S. Starrett receive at NEO?
Carolyn S. Starrett received 14,125 Restricted Stock Units from NEOGENOMICS INC on 2026-06-23. Each RSU represents one share of common stock upon vesting, and once vested, the underlying common shares are not subject to expiration according to the footnote.
What are the key terms of Carolyn S. Starrett’s new stock options at NEOGENOMICS INC?
Starrett was granted stock options covering 9,784 shares of NEOGENOMICS INC common stock on 2026-06-23. The options have an exercise price of $11.20 per share and an expiration date of 2036-06-01, with underlying common shares not expiring once vested.
Are Carolyn S. Starrett’s new NEOGENOMICS equity awards open-market purchases or compensation grants?
The Form 4 classifies both transactions with code “A,” described as a grant, award, or other acquisition. This indicates the 14,125 RSUs and 9,784 stock options were awarded to Carolyn S. Starrett, rather than acquired through open-market purchases of NEOGENOMICS INC stock.
Does Carolyn S. Starrett hold these NEOGENOMICS equity awards directly or indirectly?
The filing lists both the 14,125 Restricted Stock Units and the 9,784 stock options as directly owned by Carolyn S. Starrett. The ownership code is “D” for direct, and there is no footnote indicating that another entity holds voting or investment authority.
AI-generated analysis. How Rhea-AI works. Not financial advice.
